Logo image of NVNO

ENVVENO MEDICAL CORP (NVNO) Stock Price, Quote, News and Overview

NASDAQ:NVNO - Nasdaq - US29415J1060 - Common Stock - Currency: USD

2.735  +0 (+0.18%)

NVNO Quote, Performance and Key Statistics

ENVVENO MEDICAL CORP

NASDAQ:NVNO (4/25/2025, 8:00:01 PM)

2.735

+0 (+0.18%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High6.48
52 Week Low2.03
Market Cap47.97M
Shares17.54M
Float17.35M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)05-05 2025-05-05/bmo
IPO05-31 2018-05-31


NVNO short term performance overview.The bars show the price performance of NVNO in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 20

NVNO long term performance overview.The bars show the price performance of NVNO in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40

The current stock price of NVNO is 2.735 USD. In the past month the price decreased by -3.36%. In the past year, price decreased by -47.2%.

ENVVENO MEDICAL CORP / NVNO Daily stock chart

NVNO Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 26.96 223.47B
ISRG INTUITIVE SURGICAL INC 67.35 184.36B
BSX BOSTON SCIENTIFIC CORP 37.74 150.72B
SYK STRYKER CORP 29.95 139.34B
MDT MEDTRONIC PLC 15.76 107.94B
BDX BECTON DICKINSON AND CO 14.74 58.89B
EW EDWARDS LIFESCIENCES CORP 29.25 44.70B
IDXX IDEXX LABORATORIES INC 38.88 35.45B
RMD RESMED INC 25.98 34.64B
GEHC GE HEALTHCARE TECHNOLOGY 15.24 31.33B
DXCM DEXCOM INC 43.43 28.10B
PHG KONINKLIJKE PHILIPS NVR- NY 15.84 23.53B

About NVNO

Company Profile

NVNO logo image enVVeno Medical Corp. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. The company is headquartered in Irvine, California and currently employs 37 full-time employees. The company went IPO on 2018-05-31. The firm is focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The firm is developing surgical and non-surgical replacement venous valves for patients suffering from severe chronic venous insufficiency (CVI) of the deep venous system of the leg. The Company’s lead product is the VenoValve, which is a surgical replacement venous valve that is being evaluated in a U.S. pivotal study. The VenoValve is implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The firm is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the veins of the leg, and back to the heart and lungs.

Company Info

ENVVENO MEDICAL CORP

70 Doppler

Irvine CALIFORNIA US

CEO: Robert Berman

Employees: 31

Company Website: https://envveno.com/

Investor Relations: https://envveno.com/investors/

Phone: 19492612900

ENVVENO MEDICAL CORP / NVNO FAQ

What is the stock price of ENVVENO MEDICAL CORP today?

The current stock price of NVNO is 2.735 USD. The price increased by 0.18% in the last trading session.


What is the ticker symbol for ENVVENO MEDICAL CORP stock?

The exchange symbol of ENVVENO MEDICAL CORP is NVNO and it is listed on the Nasdaq exchange.


On which exchange is NVNO stock listed?

NVNO stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for ENVVENO MEDICAL CORP stock?

7 analysts have analysed NVNO and the average price target is 16.83 USD. This implies a price increase of 515.36% is expected in the next year compared to the current price of 2.735. Check the ENVVENO MEDICAL CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ENVVENO MEDICAL CORP worth?

ENVVENO MEDICAL CORP (NVNO) has a market capitalization of 47.97M USD. This makes NVNO a Nano Cap stock.


How many employees does ENVVENO MEDICAL CORP have?

ENVVENO MEDICAL CORP (NVNO) currently has 31 employees.


What are the support and resistance levels for ENVVENO MEDICAL CORP (NVNO) stock?

ENVVENO MEDICAL CORP (NVNO) has a resistance level at 2.75. Check the full technical report for a detailed analysis of NVNO support and resistance levels.


Should I buy ENVVENO MEDICAL CORP (NVNO) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ENVVENO MEDICAL CORP (NVNO) stock pay dividends?

NVNO does not pay a dividend.


When does ENVVENO MEDICAL CORP (NVNO) report earnings?

ENVVENO MEDICAL CORP (NVNO) will report earnings on 2025-05-05, before the market open.


What is the Price/Earnings (PE) ratio of ENVVENO MEDICAL CORP (NVNO)?

ENVVENO MEDICAL CORP (NVNO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.27).


What is the Short Interest ratio of ENVVENO MEDICAL CORP (NVNO) stock?

The outstanding short interest for ENVVENO MEDICAL CORP (NVNO) is 2.48% of its float. Check the ownership tab for more information on the NVNO short interest.


NVNO Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to NVNO. When comparing the yearly performance of all stocks, NVNO is a bad performer in the overall market: 85.52% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

NVNO Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to NVNO. NVNO has a great financial health rating, but its profitability evaluates not so good.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NVNO Financial Highlights

Over the last trailing twelve months NVNO reported a non-GAAP Earnings per Share(EPS) of -1.27. The EPS increased by 35.2% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -48.54%
ROE -51.75%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%16.67%
Sales Q2Q%N/A
EPS 1Y (TTM)35.2%
Revenue 1Y (TTM)N/A

NVNO Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 86% to NVNO. The Buy consensus is the average rating of analysts ratings from 7 analysts.


Ownership
Inst Owners24.24%
Ins Owners0.93%
Short Float %2.48%
Short Ratio4.7
Analysts
Analysts85.71
Price Target16.83 (515.36%)
EPS Next Y2.02%
Revenue Next YearN/A